Health Care & Hospital Law
Jun. 4, 2011
US Government’s Crackdown on Corruption Targets Health Care Industry
The trend of greater focus on the health care industry for Foreign Corrupt Practices Act violations may significantly impact California. By Thomas W. McNamara of Ballard Spahr LLP
As California continues to be a key player in the health care industry, pharmaceutical and medical-device companies in the state are finding themselves increasingly susceptible to the federal government's crackdown on corruption in the industry.
The U.S. Department of Justice has been aggressively enforcing the Foreign Corrupt Practices Act (FCPA), a federal anti-bribery statute that prohibits paying, offering to pay, promisin...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In